key: cord-0783500-56iynhmi
authors: Saxena, Parul; Pradhan, Indira P.; Kumar, Deepak
title: Redefining bio medical waste management during COVID- 19 in india: A way forward
date: 2021-10-12
journal: Mater Today Proc
DOI: 10.1016/j.matpr.2021.09.507
sha: a3a46ac0faa6b4b430df83d727159410a7ab098e
doc_id: 783500
cord_uid: 56iynhmi

India is ranked 120 among 165 nations with respect to sustainable development and critically suffers from insufficient waste treatment provisions and amenities. And the abrupt occurrence of the COVID-19 virus has aggravated the issue of managing of medical waste in India, manifolds. As a result, the safe disposal of a huge volume of hazardous medical waste has become a top priority. This conceptual study evaluates India's management of medical waste during the COVID-19 pandemic. Additionally, this article aims to highlight the inadequacies in India's implementation of the BMW 2016 standards by a synthesis of multiple agency reports (government and non-government) and data obtained directly from the Central Pollution Control Board (CPCB). The findings indicate that India is well behind in terms of COVID-19 waste management and requires comprehensive monitoring and implementation systems to enable the achievement of SDGs related to environmental health.

Biomedical waste (BMW) is a substantial pollutant generated in the healthcare sector as a result of operations such as medical diagnosis, treatment, and vaccination of humans and animals, as well as biological research and development. Several studies have been published on this topic (Datta et al., 2018; Ilyas et al., 2020; Shaida and Singla, 2019) . According to the World Health Organization (WHO,2018), the composition of bio-medical waste is as follows-nonhazardous waste (85%) and hazardous waste (15 %), with infectious waste accounting for 10 percent and radioactive or chemical waste accounting for 5 percent, every year, it is estimated that more than 5.2 million people, including 4 million children, die as a result of diseases caused by medical waste throughout the world (Rahman et al., 2020) . It has been determined that the severe acute respiratory syndrome, commonly known as Coronavirus disease (COVID-19) was responsible for the sudden increase in healthcare waste generation. Public health and the environment have been put to grave dangers as a result of this increased BMW. Moreover, given the technical, practical, and budgetary restrictions, India is already rassling with poor BMW practices which has been compounded by a dramatic surge in the volume of medical waste due to COVID-19. The WHO has declared a global public health emergency in response to the COVID-19 outbreak in Wuhan, China (WHO, 2020a). By March 12th, 2021, 219 countries had been affected, claiming 2.62 million lives out of 110.82 million confirmed cases (WHO, 2020b). In India, around 11,30 million confirmed positive cases, and 0,15 million deaths are reported (as of March 12th, 2021). (MoHFW). Annual BMW growth in India is 7% with estimated estimates of up to 775,5 metric tonnes per day by 2022 (Das et al., 2020) . There are 2,907 hospitals, 20,707 quarantine camps, 1539 collecting sites, and 264 testing laboratories in India involved in the generation of COVID-19 waste (CPCB, 2020a). The overall COVID-19 generation of BMW is also shown to be roughly 101mt/day. Maharashtra, Kerala, Gujarat, Andhra Pradesh, and Delhi were the top 5 BMW generating states in December 2020, according to current figures. Thus, from the given statistics, it is obvious that the on-going pandemic has worsened the seriousness of the BMW industry's issues in India. Because the infrastructural treatment capacity of India was already insufficient and because COVID-19 instances have exceeded the 11-million-mark, BMW safety disposal is a greater concern. For this reason, preventative actions are urgently needed to reduce BMW growth and avoid public health and environmental hazards. The present study presents a full evaluation of the production, collecting and management of BMW throughout the 28 States and eight UTs of India prior to and during the COVID-19 epidemic. As reported in CPCB 2019 annual report, 29,062 no. of HCFs/CBWTFs observed to be violating the provisions of the BMW Rules. CPCB's annual report for 2018/19, states that 23,942 HCFs were found to have breached the BMW regulations in 2016, and 18,210 HCFs were issued a warning as a result of their violations. The report reveals that India has a tremendous amount of BMW generation per day, and that approximately 13 percent of HCFs have broken BMW regulations, demonstrating the country's inadequate biomedical handling and management. (Central pollution control board Annual Report 2018/2019.). The precise amount of BMW produced is difficult to calculate, although one study suggests that the increase in BMW production could be as much as six-fold when compared to the scenario before the outbreak of the virus (Y. Ma, X. Lin, A. Wu, et al.,2020).

Approximately 619 tonnes of biomedical waste per day were generated by 3,22,425 healthcare facilities during the fiscal year 2018-2019. (CPCB 2019). Only 544 tonnes of biomedical waste was processed and disposed of daily, out of 619 tonnes by 202 CBWTFs and 18,015 captive treatment facilities built by healthcare facilities. Around 74 tonnes of biomedical waste per day might be disposed of by deep graves in remote locations. Assam, Bihar, Chhattisgarh, Jammu & Kashmir, Karnataka, Kerala, Madhya Pradesh, Maharashtra, Manipur, Nagaland, Odisha, and Rajasthan are the states with the greatest disparity in biomedical waste generation and treatment. 

During the second wave of the pandemic, the recently released report titled 'State of India's Environment in Figures 2021' reported a significant increase in the generation of Covid-19 related biomedical waste (BMW) The report mentions that, "India produced 139 tonnes per day of Covid-19-related biomedical waste in April 202 and in May 2021, the figure escalated to 203 tonnes per day, an increase of 46 per cent". Thus, COVID-19 has undoubtedly placed India's biomedical waste management in an appalling state. This has also highlighted one of the major challenges posed by improper disposal of biomedical waste during the Covid-19 pandemic. India's COVID-19 waste management is marred by many flaws such as non-reporting/ under-reporting, poor segregation and lack of responsiveness. The situation has been further graved by the novel coronavirus disease (COVID-19). With its prolonged stay and spread, the face of bio clutter is rapidly changing in the country. This COVID-19 waste could further foster the novel coronavirus and other infectious pathogens. And be as harmful to humans and the environment as any other bio-medical waste. Thus, this conceptual study highlights the gaps in the implementation of BMW rules during COVID-19 in India. It also attempts to make recommendations for better bio-waste management

The following materials and methods have been employed for this study:

This study is based on a survey of existing literature, news stories, and reports of information obtained from public reports and official websites by the government and not government agencies. The information presented here comes from multiple sources published on the WHO, the PIB Ministry of Health and Family Welfare websites (MoHFW). Literature has been obtained from reputable databases such as Springer, Research Gate, and Google Scholar through electronic means. No systematic sequence for the selection of sources was followed.

To demonstrate the shortcomings in the application of BMW guidelines, the researchers gathered data from government publications (Gap analysis compliance report, CPCB, 2020 and COVID -19 Medical waste Status Report May 2021). These papers explicitly noted the disparity in BMW regulation compliance among India's States and Union Territories by examining the twelve indicators indicated above (see to introduction). However, for the purpose of this, study the authors have selected the following five important indicators, for which the data was available for almost all of the states:

 Facilities for the treatment of common biomedical waste (CBMWTFs) are available.  Adequacy of existing treatment facility  Use of deep burial  Training and awareness programs conducted  Implementation of CPCB Waste tracking App.

When the pandemic tightened up its hold on the country, the COVID-19 litter was designated as hazardous biomedical waste because of the inherent risk by the Central Pollution Control Board (CPCB). The CPCB has published monthly since March 2020 directions under the 2016 Bio-Medical Trash Management Rules to ensure that COVID-19 waste is collected with the greatest care. Additionally, it has published recommendations for the transportation and storge of this garbage to "biomedical waste treatment and disposal facilities." These facilities are dedicated to the management of biohazardous waste generated by health camps, morgues, hospitals, pathological and clinical laboratories, and other medical organisations. The BMW management rules for 2016 require health centres to adopt a color-coded waste-separation system and to transmit waste within 48 hours to treatment facilities. After sterilisation, a substantial amount of garbage is sent to a recycling facility in red and blue bags and white containers. The colour coded criteria for the correct disposal of biomedical waste as shown in Figure 2 are as follows:

 Yellow Bin: For the collection of anatomical waste, chemical waste and dirty garbage. Chemotherapy waste, medicinal products and laboratory garbage disposed of.  Red Bin: To be used for Contaminated plastic waste  Blue Bin: To be used for Glass waste and metallic implants  White Bin: To be used for Metal sharps  Black Bin: To be used for Hazardous and Other waste  Green Bin: To be used for Biodegradable General waste The details of bio-medical waste (category -wise) generated by some major Central Government Hospitals under Ministry of Health and Family Welfare are as below: Table 2 ) gives a detailed information about the three important indicators selected for this study. In May 2021, India had a greatest number of new instances, with COVID-19 inducing bio-waste being 33% of the total biomedical waste created in that country. The additional pressure appears to have collapsed the country's already over-burdened biomedical waste treatment system. In this month, the volume of bio trash generated was enormous. Sates like Haryana, COVID-19 trash accounted for 47% of the biomedical waste, 42% for Chhattisgarh second, 40% for Himachal Pradesh and 40% for Andhra Pradesh and 39% in Delhi. Furthermore, the examination of the CPCB records from January and May 2021 reveals that 22 out of 36 states and Union territories generated more biomedical waste than they were capable of handling during that period. Because of the proliferation of the virus, biomedical waste treatment facilities in states such as Maharashtra, Goa, Manipur, Andhra Pradesh, Meghalaya, Rajasthan are almost saturated.

CBWTF capacity is insufficient for states like Jammu Kashmir, and one facility cannot meet the needs of the entire state. The treatment facilities were poorly equipped to handle the surge in COVID-19 waste at its peak (about 754 tonnes per day) in September 2020 or in May 2021. The picture surely seems appalling on comparison of the waste generated by each of the states with the available treatment capacity.

The numerous sources of COVID-19 waste present a significant obstacle to monitoring the flow. Due to the fact that these sources range from private residences to isolation centres and temporary quarantine camps, it's impossible to keep track of their generation and treatment. For this reason, the CPCB mandates COVID-19 waste generators in states and union territories to submit statistics on generation and treatment on a regular basis. And to that end, the 

Indi has stated a rigorous campaign In January 2021 and has been making sincere efforts to vaccinate its population. This is definitely good news but at the same time it is also alarming because every injection result in a waste syringe, and every 10-20 shots of vaccine generate glass vial waste, all of which ultimately adds up to bio medical waste. Further, due to lack of proper storage facilities a significant number of vials are discarded after few hours of opening adding to the litter. Using self-disabled syringes protects vaccine users and healthcare providers, limiting the use of syringes twice but at the same time creates a big volume of biomedical waste. Also, the central government is expected to take the responsibility of disposing of 1.3 billion syringes & needles and over 100 million wasted glass vials, as stated in the COVID-19 operations guidelines on vaccines issued on 28 December 2020 that may be generated at the end of vaccination campaign. The disposal of medical masks, face shields, gloves, shoe coverings and protective equipment are another important obstacle (PPE). These protective paraphernalia can be easily found littered all around.

Awareness needs to be created among different stakeholders for its proper treatment and sterilisation even before it is sent for recycling and the autoclave may be of serious concern in this context. As the volunteers in the vaccination centres are not trained and knowledgeable, it was also noticed that the majority of plastic, metal and glass components are sold to local wholesalers.

The following study gives a full evaluation of the generation and treatment of COVID-19 waste. It also seeks to highlight the shortcomings in India's current waste management system. The data show that most Indian states/UTs have low COVID-19 waste management performance in conjunction with the earlier study (Rajak et al. 2020 ). In their study, the authors have assessed gaps in compliance of BMWM Rules over a period of five years (2014-18) and concluded that there much left to be done in terms of handling of bio-medical waste in India. Note that the sudden surge in biomedical waste generation has created a severe scenario in States with 70 percent or greater incinerator capacity utilisation. It is also observed that due to poor awareness and lack of communication, there is poor segregation. This results in incineration of large quantity of contaminated plastics which leads to scaling of the incinerators' inner lining thereby decreasing their efficiency. Moreover, this plastic burning also adds up to the air pollution as it releases toxic gases like dioxins and furans. Mixing common waste material with bio -medical waste would cause additional burden on CBWTF incinerators not intended for the treatment of residential solid waste.

This study not only give a picture of the current scenario in terms of bio medical waste management but also highlights the deep gap in terms of the compliance of BMWM rules 2016 by the concerned stakeholders. Thus, it may help policy makers, monitoring bodies, researchers and academicians design efficient BMW management with vigorous execution strategies. It is high time that sincere efforts are made by the concerned authorities for the safe handling and disposal of COVID-19 waste to make sure that it does not mount into a big catastrophe.

Though this study provides a comprehensive overview of the disposal and treatment of biomedical waste it just takes into account the data available for the past one and half year. Therefore, this study represents only the current scenario of BMW generation in India. Further, it does not employ any statistical analysis Hence, for the future research it would be prudent to gauge the scenario of BMW in India over the years through statistical analysis.

In accordance with the BMWM Rules 2016, only litters wrapped in yellow bags, notably pathological and laboratory waste should be incinerated when health facilities follow the protocol, although home quarantine centres cannot be equated with this protocol. In the absence of proper guidelines and monitoring, home quarantine centres rarely engage themselves in the proper segregation of COVID-19 waste. Further, the guidelines mention discarding of PPE kits, goggles and other paraphernalia in the red bag which is for the collection of contaminated plastic waste to be sent for sterilisation and recycling. But in the absence of red bags distribution in home quarantine centres, these facilities throw food waste, masks, PPE kits, disposable cutlery and gloves into yellow bags, which are then sent for incineration.

In accordance with the findings of this investigation, the states/UTs that in recent months have generated COVID-19 waste at an average of 100 mt/month (December 2020-May 2021) should be controlled with a feeling of urgency and high priority. It is also proposed that all states / UTs designate their districts according to their BMW status and treatment ability as low, medium, and high priority zones. As it would be easy for the authorities involved to scale up the installations according to their categories. These provisions can then be periodically monitored to improve their BMW treatment capability to achieve an effective waste management system. Government and policymakers should promote the promotion of alternative treatment techniques such as autoclaving, mechanical and chemical disinfection to alleviate the strain on common biomedical waste treatment facilities. It is not only the Central Pollution Control Board (CPCB) that should give data that can be separated from generating sources, waste types, and treatment plants, but also ensure the adequacy of the plant and the ecosystem. CPCB should likewise take serious measures concerning the quantity of production in rural areas and general procedures for disposal of biomedical COVID-19 waste. Some of the measures that can be taken rigorously by CPCB to deal with the waste generated out of the severe pandemic outbreaks are mentioned below:

Waste Management During COVID-19 Pandemic, Press Information Bureau, Ministry of Family Welfare

Information on Managing Waste Potentially Contaminated by COVID 19, Government of Alberta

Ministry of Environment, Forest, and Climate Change

Annual Report on Biomedical Waste Management as per Biomedical Waste Management Rules

CPCB (2020a) ENVIS centre on control of pollution water, air and noise, ministry of environment, forests, and climate change. Government of India. Central Pollution Control Board

ENVIS centre on control of pollution water, air and noise, ministry of environment, forests, and climate change. Government of India. Central Pollution Control Board

CPCB (2020c) COVID-19 waste management. Central Pollution Control Board

Central Pollution Control Board

Biomedical waste management: the challenge amidst COVID-19 pandemic

Biomedical waste management in India: Critical appraisal

Disinfection technology and strategies for COVID-19 hospital and bio-medical waste management. Science of the Total Environment

COVID-19 Status of India. Ministry of Health and Family Welfare. Government of India

Biomedical waste amid COVID-19: perspectives from Bangladesh. The Lancet. Global Health

Assessment of bio-medical waste before and during the emergency of novel Coronavirus disease pandemic in India: A gap analysis

Global biomedical waste management issues and practices

WHO (2020a) Water, sanitation, hygiene, and waste management for SARS-CoV-2, the virus that causes COVID-19. The World Health Organization

WHO (2020b) Coronavirus disease (COVID-19) dashboard

Suggested guidelines for emergency treatment of medical waste during COVID-19: Chinese experience. Waste Disposal & Sustainable Energy

Parul Saxena: Conceptualization, Structuring & Writing of the manuscript, Comparison Charts Ms Indira P. Pradhan: Data assimilation, Supervision & Inspection Deepak Kumar : Figure Generation